ANI PAVLI: Open Payments
NPI 1124620604 · LAWRENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,046 in 95 payments from 16 companies in 2025. Trend: 2023 $3,195 · 2024 $2,935 · 2025 $2,046
Food & beverage: $2,046
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $573 |
| AstraZeneca Pharmaceuticals LP | 15 | $306 |
| PFIZER INC. | 13 | $255 |
| Lilly USA, LLC | 6 | $150 |
| Sumitomo Pharma America, Inc. | 7 | $144 |
| Novo Nordisk Inc | 6 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $98 |
| Astellas Pharma US Inc | 4 | $94 |
| Phathom Pharmaceuticals, Inc. | 5 | $79 |
| Exact Sciences Corporation | 2 | $53 |
Products named: VRAYLAR, LINZESS, FARXIGA, GEMTESA, CREON, JARDIANCE, ELIQUIS, BREZTRI.
Industry payments across MA — which companies pay providers there.
